THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) GAG GENE-PRODUCT P18 IS RESPONSIBLE FOR ENHANCED FUSOGENICITY AND HOST RANGE TROPISM OF THE HIGHLY CYTOPATHIC HIV-1-NDK STRAIN

被引:14
作者
DEMAREUIL, J [1 ]
BRICHACEK, B [1 ]
SALAUN, D [1 ]
CHERMANN, JC [1 ]
HIRSCH, I [1 ]
机构
[1] INSERM,U322,UNITE RECH RETROVIRUS & MALADIES ASSOCIEES,CAMPUS UNIV LUMINY,BP 33,F-13273 MARSEILLE,FRANCE
关键词
D O I
10.1128/JVI.66.11.6797-6801.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Formation of large syncytia and rapid cell killing are characteristics of the Zairian human immunodeficiency virus type 1 isolate HIV-1-NDK, which is highly cytopathic for CD4+ lymphocytes in comparison with the HIV-1-LAV prototype. Chimeric viruses containing different combinations of HIV-1-NDK genetic determinants corresponding to the splice donor, the packaging signal, and the coding sequence of the p18gag protein together with the HIV-1-NDK EcoRI5278--XhoI8401 fragment were obtained by polymerase chain reaction-directed recombination. Phenotypic analysis of recombinant viruses indicated that 75 amino acids from the N-terminal part of HIV-1-NDK p18gag protein together with the HIV-1-NDK envelope glycoprotein are responsible for enhanced fusogenicity of HIV-1-NDK in CD4+ lymphocytes as well as for enhanced infectivity of HIV-1-NDK in some CD4- cell lines. The HIV-1-NDK splice donor/packaging sequence and the sequence encoding the gag protein 25 were not important for the variation observed in HIV-1 fusogenicity.
引用
收藏
页码:6797 / 6801
页数:5
相关论文
共 41 条
[1]   HGP-30, A SYNTHETIC ANALOG OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) P17, IS A TARGET FOR CYTOTOXIC LYMPHOCYTES IN HIV-INFECTED INDIVIDUALS [J].
ACHOUR, A ;
PICARD, O ;
ZAGURY, D ;
SARIN, PS ;
GALLO, RC ;
NAYLOR, PH ;
GOLDSTEIN, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7045-7049
[2]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[3]   NEF PROTEIN OF HIV-1 IS A TRANSCRIPTIONAL REPRESSOR OF HIV-1 LTR [J].
AHMAD, N ;
VENKATESAN, S .
SCIENCE, 1988, 241 (4872) :1481-1485
[4]  
ASJO B, 1986, LANCET, V2, P660
[5]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[6]  
BLOMBERG J, 1990, New Biologist, V2, P1044
[7]   HIV-1 INFECTIVITY OF HUMAN CARCINOMA CELL-LINES LACKING CD4 RECEPTORS [J].
BRICHACEK, B ;
DERDERIAN, C ;
CHERMANN, JC ;
HIRSCH, I .
CANCER LETTERS, 1992, 63 (01) :23-31
[8]   HOST RANGE, REPLICATIVE, AND CYTOPATHIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE DETERMINED BY VERY FEW AMINO-ACID CHANGES IN TAT AND GP120 [J].
CHENGMAYER, C ;
SHIODA, T ;
LEVY, JA .
JOURNAL OF VIROLOGY, 1991, 65 (12) :6931-6941
[9]   VIRAL DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 T-CELL OR MACROPHAGE TROPISM, CYTOPATHOGENICITY, AND CD4 ANTIGEN MODULATION [J].
CHENGMAYER, C ;
QUIROGA, M ;
TUNG, JW ;
DINA, D ;
LEVY, JA .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4390-4398
[10]   SOLUBLE CD4 BLOCKS THE INFECTIVITY OF DIVERSE STRAINS OF HIV AND SIV FOR T-CELLS AND MONOCYTES BUT NOT FOR BRAIN AND MUSCLE-CELLS [J].
CLAPHAM, PR ;
WEBER, JN ;
WHITBY, D ;
MCINTOSH, K ;
DALGLEISH, AG ;
MADDON, PJ ;
DEEN, KC ;
SWEET, RW ;
WEISS, RA .
NATURE, 1989, 337 (6205) :368-370